Page 852 - Traité de chimie thérapeutique 6 Médicaments antitumoraux
P. 852

810                                   RESISTANCE AUX ANTTTUMORAUX

              MRP
              COLE S.P.C, DEELEY R.G., Multidrug resistance mediated by the ATP-binding cassette
                transporter protein MRP, BioEssays, 1998, 20, 931-940.
              BORST P. et al., The multidrug resistance protein family, Biochimica et Biophysica Acta,
                1999, 347-357.
              COLE S.P.C., Characterization of MOAT-C and MOAT-D, new members of the
                MRP/cMOAT subfamily of transporter proteins, J. Nat. Cancer Inst., 1999, 91, 888-
                889.
              KÔNIG J. et al., Conjugale export pumps of the multidrug resistance protein (MRP)
                family : localization, substrate specificity and MRP2-mediated drug resistance, Bio-
                chimica et Biophysica Acta, 1999, 1461, 377-394.
              BORST P. et al., A family of drug transporters: the multidrug resistance-associated pro-
                teins, J. Nat. Cancer lnst., 2000, 92, 1295-1301.
               LEE K et al., Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells,
                J. Nat. Cancer Inst., 2000, 92, 1934-1940.

               BCRP
               DOYLE L.A. et al., A multidrug resistance transporter from human MCF-7 breast cancer
                 cells, Proc. Nat/. Acad. Sei., États-Unis, 1998, 95, 15665-15670.
               M. MALIEPAARD M. et al., Overexpression of the BCRPIMXRIABCP gene in a topo-
                 tecan-selected ovarian tumor cell line, Cancer Research, 1999, 59, 4559-4563.
               ROSS D.D., Atypical multidrug resistance : breast cancer resistance protein messenger
                 RNA expression in mitoxantrone-selected cell lines, J. Nat. Cancer Inst., 1999, 91 (5),
                 429-433.
               JONKER J. W. et al., Role of breast cancer resistance protein in the bioavailability and
                 fetal penetration of topotecan, J. Nat. Cancer lnst., 2000, 92, 1651-1656.
               SCHEFFER G.L., Breast cancer resistance protein is localized at the plasma membrane
                 in mitoxantrone and topotecan-resistant cell lines, CancerResearch, 2000, 60, 2589-
                 2593.
               VOLK E.L. et al., Methotrexate cross-resistance in a mitoxantrone-selected multidrug-
                 resistant MCF7 breast cancer line is attributable to enhanced energy-dependent drug
                 efflux, Cancer Research, 2000, 60, 3514-3521.
               MALIEPAARD M. et al., Subcellular localization and distribution of the breast cancer
                 resistance protein transporter in normal human tissues, Cancer Research, 2001, 61,
                 3458-3464.
               LRP/MVP
               DALTON W.S., SCHEPER R.J., Lung resistance-related protein : determining its role in
                 multidrug resistance, J. Nat. Cancer Inst., 1999, 91, 1604-1605.
               KITAZONO M. et al., Multidrug resistance and the lung resistance associated protein in
                 human colon carcinoma SW-620 cells, J. Nat. Cancer Inst., 1999, 91, 1647-1653.
               SCHROEIJERS A.B. et al., The Mr 193,000 vault protein is up-regulated in multidrug-
                 resistant cancer cell lines, CancerResearch, 2000, 60, 1104-1110.
               Sites internet: http://vaults.arc.ucla.edu/sci/
               http://vaults.arc.ucla.edu/Bulletin.htm
   847   848   849   850   851   852   853   854   855   856   857